Why the study?
Patients developing pulmonary artery stenosis after the arterial switch operation for transposition of the great arteries were encountered with atypical complications during pulmonary artery stenting.
What are the risks of pulmonary artery interventions in patients after the arterial switch operation?
What are the risks of pulmonary artery interventions in patients after the arterial switch operation?
Answers are grounded in this paper and cite their sources.
Percutaneous intervention for pulmonary artery stenosis after the arterial switch operation carries a high risk of major adverse events, including aorto-pulmonary fistulae and coronary compression, necessitating careful pre-procedural evaluation.
BACKGROUND: In the modern era, results of the arterial switch operation (ASO) for transposition of the great arteries are excellent. However, because of the LeCompte maneuver, there may be a propensity for development of pulmonary artery stenosis. We encountered atypical complications of pulmonary artery stenting in patients after the ASO, including aorto-pulmonary fistula and coronary compression. METHODS: We performed a 10-year retrospective review of catheterizations performed in patients after ASO in our institution with a focus on adverse events. RESULTS: Diagnostic and interventional catheterizations were performed in 47 patients. In 29 patients, 37 interventional procedures performed, which included pulmonary artery angioplasty and/or stenting. In this group, there were five major adverse events (14%), including three aorto-pulmonary fistulae and one coronary artery compression among patients having stent implantation or stent redilation. In addition, there were 6/37 (16%) intended stent procedures, which were aborted because there appeared to be high-risk of significant adverse events. CONCLUSIONS: This review suggests that percutaneous intervention on pulmonary artery stenosis after ASO has high-risk and should be undertaken advisedly. Prior thorough evaluation of coronary arteries is mandatory as coronary reimplantation sites may be adjacent to sites of pulmonary artery stenosis. Furthermore, if pulmonary artery stent implantation or stent redilation is contemplated, the risk of stent fracture and possible AP fistula should be recognized. Primary use of reinforced covered stents should be considered.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: